Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?

Key Takeaways Pfizer will report Q3 2025 earnings before market open, with sales estimated at $16.6 billion.Earnings estimates have fallen to $3.06 per share amid rising costs from recent acquisitions.Higher sales of Vyndaqel, Padcev and Eliquis may have supported growth despite IRA headwinds.Pfizer (PFE) will report its third-quarter 2025 earnings on Nov. 4, before market open. The Zacks Consensus Estimate for sales and earnings for the third quarter is pegged at $16.6 billion and 66 cents per share, respe ...